ImmunoGenesis Patents – Insights & Stats (Updated 2023)

ImmunoGenesis has a total of 56 patents globally, out of which 41 have been granted. Of these 56 patents, more than 83% patents are active. The United States is where ImmunoGenesis has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the US seems to be the main focused R&D center of ImmunoGenesis and is also the origin country of the firm.

ImmunoGenesis was founded in the year 2019 by Michael Curran and William Tanner. The company specializes in science-driven immune therapies for tumor treatment.

Do read about some of the most popular patents of ImmunoGenesis which have been covered by us in this article and also you can find ImmunoGenesis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ImmunoGenesis patent portfolio.

How many patents does ImmunoGenesis have?

ImmunoGenesis has a total of 56 patents globally. These patents belong to 13 unique patent families. Out of 56 patents, 47 patents are active.

How Many Patents did ImmunoGenesis File Every Year?

ImmunoGenesis Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantImmunoGenesis Applications FiledImmunoGenesis Patents Granted
202215
2021111
20203
20191
201832
201722
201681
201523
201413
201384
201233
201172

How many ImmunoGenesis patents are Alive/Dead?

Worldwide Patents

ImmunoGenesis Patent Portfolio

How Many Patents did ImmunoGenesis File in Different Countries?

ImmunoGenesis Worldwide Patent Filing

Countries in which ImmunoGenesis Filed Patents

CountryPatents
United States Of America19
Europe7
Japan6
Spain5
Australia5
Germany5
Canada3
Austria2
Hong Kong (S.A.R.)2
Italy1
Taiwan1

Where are Research Centres of ImmunoGenesis Patents Located?

R&D Centre of ImmunoGenesis

10 Best ImmunoGenesis Patents

US8299088B2 is the most popular patent in the ImmunoGenesis portfolio. It has received 34 citations so far.

Below is the list of 10 most cited patents of ImmunoGenesis:

Publication NumberCitation Count
US8299088B234
US20140010805A126
US7550496B214
US8003625B212
US8507464B29
US8946275B27
US20140171389A14
US8552048B22
JP5180824B22
US8664204B21

What are ImmunoGenesis’ key innovation segments?

What Technologies are Covered by ImmunoGenesis?

The chart below distributes patents filed by ImmunoGenesis in different countries on the basis of the technology protected in patents. It also represents the markets where ImmunoGenesis thinks it’s important to protect particular technology inventions.

R&D Focus: How has ImmunoGenesis’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by ImmunoGenesis?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.